Status:
COMPLETED
Conversation With Family Doctor to Increase COVID-19 Vaccine Uptake
Lead Sponsor:
Norwegian Institute of Public Health
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will randomise individuals from family doctors' lists of patients that are at risk of severe Coronavirus Disease 2019 (COVID-19), and that are not registered as having taken the vacc...
Eligibility Criteria
Inclusion
- Belonging to group at risk of severe COVID-19
Exclusion
- \-
Key Trial Info
Start Date :
December 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
654 Patients enrolled
Trial Details
Trial ID
NCT05207137
Start Date
December 3 2021
End Date
June 30 2022
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bolteløkka legesenter
Oslo, Norway, 0168